RARA CRAFT DATABASE for FDA Medical Devices
510(k)K220155

FDA DEVICE FACTS

Powder-free Nitrile Examination Gloves Tested for use with Chemotherapy Drugs

Motex Healthcare (Anhui) Co., Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMay 23, 2022PRODUCT CODELZA

Indications for use

A patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Gloves have been tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs. Chemotherapy Drug Permeation: Breakthrough TimeChemotherapy Drugs Tested Bleomycin Sulfate, 15 mg/mI (15,000 ppm) Bortezomib (Velcade), I mg/mi (1,000ppm) Busulfan, 6 mg/mI (6,000 ppm) Carboplatin, 10 mg/mI (10,000 ppm) >240 minutes >240 minutes >240 minutes >240 minutes 45 4 minutes* >240 minutes >240 minutes Carmustine (BCNU), 3.3 mg/mI (3,300 ppm) Chloroquine, 50 mg/nil (50,000 ppm) Cisplatin, 1.0 mg/mI (1,000 ppm) Cyclophosphamide (Cytoxan), 20.0 mg/mI (20,000 ppm) >240 minutes >240 minutes >240 minutes >240 minutes >240 minutes >240 minutes >240 minutes >240 minutes >240 minutes >240 minutes >240 minutes >240 minutes >240 minutes >240 minutes >240 minutes >240 minutes >240 minutes 15.6 minutes* >240 minutes >240 minutes >240 minutes Cytarabine, 100 mg/ml (100,000 ppm) Dacarbazine, 10.0 mg/mi (10,000 ppm) Daunorubicin HCI, 5 mg/mI (5,000 ppm) Docetaxel. 10 mg/mI (10,000 ppm) Etoposide, 20.0 mglml (20,000 ppm) Fluorouracil, 50 0 mg/mI (50,000 ppm) Gemcitabine, 38 mg/ml (38,000 ppm) Idarubicin HCI, 1 mg/ml (1,000 ppm) Ifosfamide, 50 mg/ml (50,000 ppm) Irinotecan, 20 mg/ml (20,000 ppm) Mechlorethamine HCI, I mg/ml (1,000 ppm) Melphalan, 5 mg/mI (5,000 ppm) Methotrexate, 25 mg/ml (25,000ppm) Mitomycin C, 0.5 mg/ml (500 ppm) Mitoxantrone, 2 mg/mI (2,000 ppm) Paclitaxel, 6.0 mg/ml (6,000 ppm) ThioTepa, 10.0 mg/mI (10,000 ppm) Triclosan, 2 mg/mI (2,000 ppm) Trisenox, I mg/ml (1,000 ppm) Vincristine Sulfate, 1 0 mg/ml (1,000 ppm) *WARNING Not recommended for use with Carmustine and ThioTepa. The maximum testing time is 240 minutes. Please note that the following drugs have low permeation times: Carmustine (BCNU), 3.3 mg/mI (3,300 ppm) ThioTepa, 10.0 mg/ml (10,000 ppm) 45.4 minutes 15.6 minutes

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026